Table 2.
Docking energy scores (kcal/mol) derived from the MOE for (3–6, 9, and 11).
Cpd. | Ref.Inhibtor | 3 | 4 | 5 | 6 | 9 | 11 |
---|---|---|---|---|---|---|---|
PPAR-γ(PDB: 2PRG) | |||||||
ΔΕ | −7.86 | −9.80 | −6.48 | −11.85 | −9.14 | −11.40 | −9.01 |
RMSD | 1.95 | 1.60 | 1.50 | 1.33 | 1.79 | 1.77 | 1.89 |
E_place | −47.36 | −112.41 | −39.25 | −37.56 | −59.86 | −89.46 | −118.45 |
E.Int. | −35.63 | −30.39 | −33.70 | −32.85 | −34.63 | −38.27 | −33.03 |
E.H.B. | −0.25 | −1.33 | 0.29 | −0.65 | −0.12 | 0.37 | −0.23 |
L.E | 4.03 | 6.76 | 4.34 | 8.88 | 5.11 | 6.46 | 4.76 |
Ki(μM) | 1.39 | 1.70 | 2.21 | 1.61 | 1.87 | 1.65 | 1.88 |
LEscale | 2.67 | 2.84 | 2.90 | 3.00 | 2.74 | 2.75 | 2.69 |
FQ | 1.36 | 3.92 | 1.44 | 5.88 | 2.37 | 3.70 | 2.07 |
α-amylase, (PDB:2QV4) | |||||||
ΔΕ | −5.59 | −6.23 | −6.50 | −6.74 | −6.14 | −7.66 | −6.33 |
RMSD | 1.79 | 0.93 | 1.33 | 1.95 | 1.95 | 1.19 | 1.37 |
E_place | −26.39 | −43.10 | −62.93 | −23.29 | 15.12 | −113.81 | −37.51 |
E.Int. | −32.26 | −24.52 | −19.04 | −24.48 | −15.75 | −26.46 | −18.00 |
E.H.B. | −17.58 | −15.46 | −10.35 | −11.87 | −10.07 | −11.36 | −10.01 |
L.E | 3.12 | 6.67 | 4.89 | 3.46 | 3.15 | 6.44 | 4.61 |
Ki(μM) | 1.14 | 2.25 | 2.21 | 2.17 | 2.27 | 2.05 | 2.24 |
LEscale | −2.74 | −3.31 | −3.00 | −2.67 | −2.67 | −3.10 | −2.97 |
FQ | 0.38 | 3.36 | 1.89 | 0.79 | 0.48 | 3.34 | 1.64 |
ΔE: free binding energy of ligand-pose which derived from gold tool, RMSD; the root mean square deviation of the docking pose compared to the co-crystal ligand position, E_place.: free binding energy of ligand-receptor. E.Int.: binding-affinity energy of ligand-receptor, E.H.B.: energy H-bonding between protein and ligand.